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Abstract
Myostatin (Mstn) knockout mice exhibit large increases in skeletal muscle mass. However,
relatively few of the genes that mediate or modify MSTN effects are known. In this study, we
performed co-expression network analysis using whole transcriptome microarray data from
MSTN-null and wild-type mice to identify genes involved in important biological processes
and pathways related to skeletal muscle and adipose development. Genes differentially ex-
pressed between wild-type and MSTN-null mice were further analyzed for shared DNAmo-
tifs using DREME. Differentially expressed genes were identified at 13.5 d.p.c. during
primary myogenesis and at d35 during postnatal muscle development, but not at 17.5 d.p.c.
during secondary myogenesis. In total, 283 and 2034 genes were differentially expressed
at 13.5 d.p.c. and d35, respectively. Over-represented transcription factor binding sites in
differentially expressed genes included SMAD3, SP1, ZFP187, and PLAGL1. The use of
regulatory (RIF) and phenotypic (PIF) impact factor and differential hubbing co-expression
analyses identified both known and potentially novel regulators of skeletal muscle growth,
including Apobec2, Atp2a2, andMmp13 at d35 and Sox2, Tmsb4x, and Vdac1 at 13.5 d.p.
c. Among the genes with the highest PIF scores were many fiber type specifying genes.
The use of RIF, PIF, and differential hubbing analyses identified both known and potentially
novel regulators of muscle development. These results provide new details of how MSTN
may mediate transcriptional regulation as well as insight into novel regulators of MSTN sig-
nal transduction that merit further study regarding their physiological roles in muscle and
adipose development.
Introduction
Myostatin (MSTN), also known as GDF8, is a transforming growth factor beta (TGFβ) super-
family member that negatively regulates skeletal muscle growth in various species [1–3].
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Previous studies have demonstrated that MSTN blockade can functionally improve dystrophic
muscle [4] and that MSTN can also play an important role in adipose development [5]. To bet-
ter understand the molecular mechanisms by which MSTN controls muscle growth and devel-
opment, microarray data fromMSTN-null and wild-type mice were used for gene co-
expression network analysis during key timepoints in skeletal muscle development. These
timepoints included primary myogenesis at 13.5 days post coitus (d.p.c.), secondary myogen-
esis at 17.5 d.p.c., and postnatal muscle growth at 35 days after birth (d35) [6–8].
In previous studies, the partial correlation and information theory (PCIT) approach and the
regulatory impact factor (RIF) algorithm have been used to evaluate the regulatory functions of
transcription factors (TFs) on gene expression [9–11]. The PCIT algorithm can be used to de-
termine the differential hubbing (DH; [9]) of targets to putative regulatory genes. A regulator
that exhibits DH across treatments will have drastically higher connectivity in one treatment
compared to the others. The RIF algorithm identifies potential regulators that are “differential-
ly wired” (i.e., differentially correlated) as a function of treatment (Mstn genotype, in the con-
text of this study). Two methods for calculating RIF assign different weights to the target gene’s
level of expression. The RIF1 score also ranks genes based on their phenotypic impact factor
(PIF; a score that combines overall expression and differential expression). RIF1 scores place
more emphasis on target transcripts highly differentially wired due to treatment, while RIF2
scores identify regulators whose expression tends to predict changes in expression of target
transcripts that are differentially expressed (DE) between treatments. Previous studies evaluat-
ing RIF scores demonstrate that genes with relatively stable expression levels in different condi-
tions (i.e., genes not differentially expressed) can still play important roles in biological
processes in a coordinated manner. But these studies have limitations: first, these analyses
mainly considered DE genes, which were quite limited and may not be representative of all the
changes that take place in response to an experimental treatment. Second, only genes with
known regulatory functions (i.e., transcription factors) were evaluated in previous studies.
Without considering all genes, it is difficult to discover novel regulators of skeletal muscle
growth.
In this study, we applied modified versions of the PCIT [12] and RIF algorithms [10,11] to
evaluate more than 34,000 annotated genes from a whole microarray dataset as potential regu-
lators of muscle and adipose development in the presence or absence of functional myostatin.
We consider the RIF method modified because all genes were tested as possible regulators
using RIF scores, whereas previous studies using this methodology considered only TFs as pos-
sible regulators. The PCIT method utilized in this anlaysis used the same methodology but was
computationally enhanced to complete the analysis in considerably less time than the original
algorithm [12]. We calculated RIF scores that contrastedMstn genotypes at each developmen-
tal timepoint to identify potential regulators ofMstn or pathways influenced by MSTN signal
transduction. Furthermore, DE genes were compared acrossMstn genotypes for differences in
the enrichment of TF binding sites, biological processes, and pathways related to MSTN
function.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the recommendations in the Animal
Guide of the United States Department of Agriculture. The protocol was approved by the Insti-
tutional Animal Care and Use committee of Iowa State University (Protocol Number: 11-05-
6013-M).
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Animals and sample collection
Animals were reared, sacrificed by CO2 asphyxiation (embryonic timepoints) or cervical disloca-
tion (d35), and tissues were collected from whole embryos (13.5 d.p.c.), hindquarters (17.5 d.p.c.),
or pectoralis muscle (d35). The pectoralis muscle was chosen at day 35 because it is the muscle
with the greatest change in muscle mass due toMstn deletion and had a high level of myostatin
expression as described in the original paper characterizing myostatin function in skeletal
muscle [2]. After collection, muscles were flash-frozen in liquid nitrogen as previously described
[13].
RNA isolation and target preparation
The frozen tissues from whole embryo or hindquarter only were immersed in RLT lysis buffer
(Qiagen, Valencia, CA) and homogenized for 45 seconds, then centrifuged at 3600g for 10 min
to pellet cell debris. Total RNA was isolated using the RNase Midi Kit (Qiagen) with on-col-
umn DNase digestion according to manufacturer's protocol. Isolation from pectoralis muscle
was conducted as described [13]. The concentration of isolated RNA was evaluated based on
absorbance at 260 nm and the quality was determined by agarose gel electrophoresis. For mi-
croarray analysis, 10 μg of RNA from each of three individual animals was pooled to give five
pools representing 15 indviduals for each genotype/timepoint combination. A final concentra-
tion of 1 μg/ml was yielded from the pooled RNA, the quality of which was reconfirmed using
the 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Microarray target preparation, hy-
bridization, and scanning were conducted as described [13].
Microarray processing
Target RNA was hybridized to both chip A and chip B of the GeneChip Mouse Expression Set
430 (MOE430; Affymetrix, Santa Clara, CA), which includes over 45,000 probe sets and 39,000
transcripts and variants, containing over 34,000 well-annotated mouse genes. Robust multi-
array analysis (RMA) was performed to normalize the raw data [14] by using R/affy package
[15]. All of the microarray data is available at NCBI GEO under accession number GSE63154.
Statistical analysis
The normalized gene expression data were used for further analysis. To detect differentially ex-
pressed genes in each genotype, expression data with five replicates were analyzed as a
completely randomized design by using R/limma package [16]. Because the tissues are different
across timepoints, the analysis was performed separately for each timepoint. The model used
for analysis was, where yij is the normalized gene expression, μ is the overall mean, Gi is the ith
genotype, and εij is the error for the jth replicate within the ith genotype. DE genes were identi-
fied at a false discovery rate (FDR)<0.05 using the q-value package from Bioconductor [17].
RIF analysis and differential hubbing
Using all of the Affy ProbesetIDs after excluding the control IDs and housekeeping genes, we
applied a modified partial correlation and information theory approach (PCIT) [10,12] to
compute the co-expression correlation between each gene pair in both MSTN-null and wild-
type conditions. Co-expression analyses were done only within timepoint since tissue types
were not identical across different developmental stages. As described in Reverter et al. [11], we
calculated the regulatory impact factors (RIF), which compute the differential wiring from the
difference in co-expression correlation of each pair of genes. A key difference in this analysis is
that we used all genes for the RIF analysis to try to identify novel regulators of muscle growth
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
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in response to lack of functional MSTN. Differential hubbing calculations were conducted
using a Perl script that captured only the significant partial correlations identified by the PCIT
algorithm. Correlates were filtered to include only those genes with |r| 0.90 to ensure that
only strong correlations were captured, given the small sample size and large amount of data.
The concept of RIF, PIF, and differential hubbing can be challenging to understand in the con-
text of biological processes. Hudson et al. [9] provide a nice description of how these co-expres-
sion methods can be used to understand the genetic regulation of muscle mass.
Annotation and pathway analysis
Annotation of ProbesetIDs is based on the annotation file from the Affymetrix website (http://
www.affymetrix.com), while the IDs without annotation were annotated using Biomart
(Ensembl, http://www.ensembl.org/biomart/martview/c56c1fc10cb311e0b5fe1c05dbd3f217)
and DAVID [18]. Differentially expressed genes and genes co-correlated to top RIF were used
to identify over-represented pathways across different developmental timepoints in web-based
DAVID, while the significant regulators of these gene lists were analyzed in Sub-Network En-
richment Analysis (SNEA) via Pathway Studio [19].
Discovering significantly over-represented motifs using DREME
Among those genes up- and downregulated between genotypes as well as co-expressed with
top RIF regulators, we applied a motif discovery method for non-redundant, statistically signif-
icant, and discriminative motifs using Discriminative Regular Expression Motif Elicitation
(DREME) [20] implemented in iPlant (http://www.iplantcollaborative.org). We used 1,500 bp
upstream flanking sequence in FASTA format. Generally, we ran the analysis using the default
settings. First, the sequences of genes of interest from up- and downregulated groups were used
for positive input sequences, while the negative sequences were the sequences of well-annotat-
ed genes from both MOE430A and MOE430B chips after excluding those genes of interest.
Second, we chose 3 as the minimum width of core motif and 8 as the maximum. Third, 0.05
was chosen as the motif e-value cutoff, where the e-value is the motif statistic p-value times the
number of candidate motifs tested, and the counts created after removing sites that matched
motifs found previously were used to calculate the p-value.
To evaluate the discovered motifs, we used TOMTOM [21] implemented in MEME Suite
(http://meme.nbcr.net/meme/intro.html) to compare the motifs with the database of known
transcription factor motifs in JASPAR (JASPAR_CORE_2009.meme; 476 motifs) [22] and
UniProbe (uniprobe_mouse.meme; 386 motifs) [23] using default settings with the significance
threshold 0.05.
Results
Differentially expressed genes
Table 1 and Table 2 present the top 20 DE genes ranked by significance at 13.5 d.p.c. and d35,
respectively. The DE genes were identified using R/limma (S1 Table) and a significance thresh-
old of FDR< 0.05. At 13.5 d.p.c., 283 genes were DE, 17 of which were downregulated and 266
of which were upregulated in WT. Surprisingly, we did not identify any differentially expressed
genes (FDR< 0.05) at 17.5 d.p.c. At d35, 2034 genes were DE, 928 of which were downregu-
lated and 1106 of which were upregulated in wild-type mice.
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
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DAVID annotation and Pathway Studio analysis of DE genes at 13.5 d.p.
c. and d35
Pathway analysis results from DAVID and Pathway Studio 9 are listed in S2 and S3 Tables.
The 283 genes DE at 13.5 d.p.c. were significantly enriched for 46 Gene Ontology (GO) terms
[24] and several PANTHER pathway terms and SP_PIR_KEYWORDS [18]. Most of the 13.5
d.p.c. DE genes were involved in the regulation of transcription, RNA processing, negative reg-
ulation of cellular biosynthetic process and transcription, nucleotide binding, transcription re-
pressor activity, and WNT signaling pathway. For the 2034 genes DE at d35, 58 GO terms,
19 SP_PIR_KEYWORDS, and several KEGG and PANTHER pathway terms were over repre-
sented. The DE genes at d35 were largely involved in muscle organ/tissue development, fatty
acid metabolism, and mitochondria. Pathway Studio results at d35 identified 100 significantly
over-represented regulator-target relationships (p< 0.05); PPARG, LEP, calmodulin, and GH1
were linked to the largest numbers of differentially expressed genes. MEF2A, MEF2C, creatine
kinase, and UCP2 were also significantly enriched in the regulator-target relationships.
Over-represented DNAmotifs in differentially expressed genes
Fig. 1 and Fig. 2 illustrate the over-represented motifs present in the promoters of DE genes at
13.5 d.p.c. (E-values< 0.05). Ten and eleven over-represented motifs were identified in DE
genes upregulated in WT and MSTN–null genotypes, respectively. Over-represented motifs at
Table 1. Top 20 WT/null differentially expressed genes ranked by signiﬁcance at 13.5 d.p.c., q < 0.05*.
ProbesetID Fold
Change^
q-Value Change
Direction
Gene
Symbol
Gene Description
1419356_at 1.94 1.44E-
05
Up Klf7 Kruppel-like factor 7 (ubiquitous)
1456257_at 0.62 0.0118 Down Fam126b family with sequence similarity 126, member B
1431686_a_at 1.22 0.0130 Up Gmfb glia maturation factor, beta
1418170_a_at 1.26 0.0130 Up Zcchc14 zinc ﬁnger, CCHC domain containing 14
1427353_at 1.27 0.0130 Up Clasp1 CLIP associating protein 1
1422528_a_at 1.28 0.0130 Up Zfp36l1 zinc ﬁnger protein 36, C3H type-like 1
1456398_at 1.29 0.0130 Up TUG1 taurine upregulated gene 1
1451730_at 1.29 0.0130 Up Zfp62 zinc ﬁnger protein 62
1431326_a_at 1.29 0.0130 Up Tmod2 tropomodulin 2
1449118_at 1.34 0.0130 Up Dbt dihydrolipoamide branched chain transacylase E2
1436746_at 1.41 0.0130 Up Wnk1 WNK lysine deﬁcient protein kinase 1
1426756_at 1.41 0.0130 Up Galnt2 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 2
1419038_a_at 1.58 0.0130 Up Csnk2a1 casein kinase 2, alpha 1 polypeptide
1431239_at 1.18 0.0135 Up Nono non-POU-domain-containing, octamer binding protein
1424398_at 1.26 0.0135 Up Dhx36 DEAH (Asp-Glu-Ala-His) box polypeptide 36
1426777_a_at 1.43 0.0139 Up Wasl Wiskott-Aldrich syndrome-like (human)
1417623_at 1.18 0.0142 Up Slc12a2 solute carrier family 12, member 2
1455886_at 1.26 0.0142 Up Cbl Casitas B-lineage lymphoma
1445199_at 1.22 0.0149 Up PATZ1 POZ (BTB) and AT hook containing zinc ﬁnger 1
1457513_at 1.22 0.0149 Up Fam40a family with sequence similarity 40, member A
*For multiple probesetIDs with the same annotation, the probesetID with smallest q-value was saved.
^Fold changes are presented as WT/null. Fold change > 1 indicates higher expression in the WT compared to the null. Fold change < 1 indicates higher
expression in the null genotype compared to the WT.
doi:10.1371/journal.pone.0117607.t001
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Table 2. Top 20 WT/null differentially expressed genes ranked by signiﬁcance at d35, q < 0.05*.
ProbesetID Fold Change^ q-Value Change Direction Gene Symbol Gene Description
1451203_at 2.28 5.65E-06 Up Mb Myoglobin
1416551_at 3.74 5.65E-06 Up Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
1427768_s_at 3.80 1.07E-05 Up Myl3 myosin, light polypeptide 3
1449997_at 4.74 1.47E-05 Up Tpm3 tropomyosin 3, gamma
1448152_at 0.40 1.67E-05 Down Igf2 insulin-like growth factor 2
1419606_a_at 5.50 1.67E-05 Up Tnnt1 troponin T1, skeletal, slow
1455450_at 1.76 1.92E-05 Up Ptpn3 protein tyrosine phosphatase, non-receptor type 3
1424831_at 0.63 2.28E-05 Down Cpne2 copine II
1448554_s_at 4.36 2.28E-05 Up Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha
Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta
1450813_a_at 4.30 5.98E-05 Up Tnni1 troponin I, skeletal, slow 1
1418370_at 4.93 5.98E-05 Up Tnnc1 troponin C, cardiac/slow skeletal
1417959_at 0.64 6.51E-05 Down Pdlim7 PDZ and LIM domain 7
1417673_at 1.77 6.51E-05 Up Grb14 growth factor receptor bound protein 14
1437025_at 0.49 7.72E-05 Down Cd28 CD28 antigen
1425153_at 1.82 7.72E-05 Up Myh2 myosin, heavy polypeptide 2, skeletal muscle, adult
1448394_at 5.08 8.62E-05 Up Myl2 myosin, light polypeptide 2, regulatory, cardiac, slow
1419145_at 2.06 9.75E-05 Up Smtnl1 smoothelin-like 1
1424937_at 1.58 9.98E-05 Up Plin5 perilipin 5
1422813_at 0.60 1.01E-04 Down Cacng1 calcium channel, voltage-dependent, gamma subunit 1
1418865_at 0.60 1.06E-04 Down Zfp385a zinc ﬁnger protein 385A
*For multiple probesetIDs with the same annotation, the probesetID with smallest q-value was saved.
^Fold changes are presented as WT/null. Fold change > 1 indicates higher expression in the WT compared to the null. Fold change < 1 indicates higher
expression in the null genotype compared to the WT.
doi:10.1371/journal.pone.0117607.t002
Fig 1. Over-representedmotifs in genes upregulated in WT at 13.5 d.p.c.
doi:10.1371/journal.pone.0117607.g001
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d35 are listed in Figures A and B in S1 File. At this timepoint, nine and ten over-represented
motifs were identified in DE genes upregulated in WT and MSTN-null genotypes, respectively.
Similar to the 13.5 d.p.c. timepoint, enriched motifs were identified in zinc-finger protein bind-
ing sites. Moreover, the SMAD3 binding site was identified as an over-represented motif in DE
genes upregulated in the MSTN-null genotype, and the SP1 binding site was found to be the
sixth most significant motif in DE genes upregulated in the WT.
Regulatory impact factor analysis
Tables 3–6 list the top ten most extreme RIF scores, ranked by Z-score, at 13.5 d.p.c. and d35.
All RIF scores are provided in S4 Table. Fig. 3 shows the relationship between RIF1 and RIF2
Fig 2. Over-representedmotifs in genes upregulated in MSTN-null at 13.5 d.p.c.
doi:10.1371/journal.pone.0117607.g002
Table 3. Top 10 RIF1 (wild type minus null) at 13.5 d.p.c.
ProbesetID RIF1 RIF2 Gene Symbol Gene Description
(1) Top Positive RIF1
1415833_x_at 10.09 -5.42 Rps29 ribosomal protein S29
1417184_s_at 8.25 2.05 Beta-s, Hbb-b1, Hbb-b2 hemoglobin subunit beta-1-like
hemoglobin, beta adult major chain
hemoglobin, beta adult minor chain
1416054_at 8.14 -2.80 Rps5 ribosomal protein S5
1416546_a_at 7.81 -1.54 Rpl6 ribosomal protein L6
1417451_a_at 7.74 -0.36 Ppia peptidylprolyl isomerase A
(2) Top Negative RIF1
1415924_at -2.50 0.23 Tnp1 transition protein 1
1416055_at -2.50 0.24 Amy2a1, Amy2a2 amylase 2a1, amylase 2a2, amylase 2a3
Amy2a3, Amy2a4, Amy2a5 amylase 2a4, amylase 2a5
1418855_at -2.49 -0.25 Lce1l late corniﬁed envelope 1L
1420239_x_at -2.45 0.21 March-2 membrane-associated ring ﬁnger (C3HC4) 2
1419792_at -2.44 0.00 Kif20b kinesin family member 20B
doi:10.1371/journal.pone.0117607.t003
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scores for the 13.5 d.p.c. and d35 timepoints. The correlation coefficient (r) between RIF1 and
RIF2 was very close to zero at 13.5 d.p.c. (r = -0.09) and moderately positive at d35 (r = 0.45).
At 13.5 d.p.c., Rps29 and Beta-s exhibited the top two RIF1 Z-scores (10.09 and 8.25, respec-
tively). At d35 after birth, Tnni2 and Tpm1 exhibited the top two RIF1 Z-scores (11.24 and
10.01, respectively). At 13.5 d.p.c., Cox6b1 and Rpl13a exhibited the top two RIF2 Z-scores
(5.79 and 5.37, respectively), and at d35, Atp2a2 and Tnni2 exhibited the top two RIF2 Z-scores
(7.84 and 7.74, respectively). Several genes were identified with top-ten RIF scores at both time-
points (i.e., Beta-s, GM10420,March-2). In addition, Tnni2 was identified in the top ten at d35
for both RIF1 and RIF2. Target genes highly connected to Tnni2 (Pearson correlation coeffi-
cient based on PCIT, |r| 0.9) were further investigated using ontology enrichment analysis to
identify potential pathways involved in muscle development. Genes highly correlated with
Table 4. Top 10 RIF2 (wild type minus null) at 13.5 d.p.c.
ProbesetID RIF2 RIF1 Gene Symbol Gene Description
(1) Top Positive RIF2
1416565_at 5.79 7.00 Cox6b1 cytochrome c oxidase, subunit VIb polypeptide 1
1417608_a_at 5.37 6.14 Rpl13a ribosomal protein L13A
1423111_at 5.30 4.01 Atp5a1 ATP synthase, H+ transporting, mitochondrial F1 complex
alpha subunit 1
1436992_x_at 5.13 3.33 Vdac1 voltage-dependent anion channel 1
1417771_a_at 5.00 3.25 Psmc6 proteasome (prosome, macropain) 26S subunit, ATPase, 6
(2) Top Negative RIF2
1435873_a_at -13.49 0.39 Gm11478, Rpl13a 60S ribosomal protein L13a-like, ribosomal protein L13A
Zfp526 zinc ﬁnger protein 526
1416141_a_at -8.12 6.90 Rps6, Rps6-ps4 ribosomal protein S6, ribosomal protein S6, pseudogene 4
1431765_a_at -7.49 7.41 Gm10420, Gm5978, Gm6139 predicted gene 10420, predicted gene 5978, predicted gene 6139
Gm8225, Gm8842, Rps2 predicted gene 8225, predicted gene 8842, ribosomal protein S2
1415906_at -5.50 6.79 Tmsb4x thymosin, beta 4, X chromosome
1415833_x_at -5.42 10.09 Rps29 ribosomal protein S29
doi:10.1371/journal.pone.0117607.t004
Table 5. Top 10 RIF1 (wild type minus null) at d35.
ProbesetID RIF1 RIF2 Gene Symbol Gene Description
(1) Top Positive RIF1
1416889_at 11.24 -0.92 Tnni2 troponin I, skeletal, fast 2
1423049_a_at 10.01 -0.50 Tpm1 tropomyosin 1, alpha
1416478_a_at 9.46 1.25 Mdh2 malate dehydrogenase 2, NAD (mitochondrial)
1416921_x_at 9.38 1.40 Aldoa, Aldoart1 aldolase A, fructose-bisphosphate, aldolase 1 A retrogene 1
1417184_s_at 9.32 2.05 Beta-s hemoglobin subunit beta-1-like
Hbb-b1 hemoglobin, beta adult major chain
Hbb-b2 hemoglobin, beta adult minor chain
(2) Top Negative RIF1
1417051_at -2.11 -0.04 Pcdh8 protocadherin 8
1420239_x_at -2.08 0.21 March2 membrane-associated ring ﬁnger (C3HC4) 2
1416744_at -2.07 0.20 Uap1 UDP-N-acetylglucosamine pyrophosphorylase 1
1416967_at -2.07 -1.26 Sox2 SRY-box containing gene 2
1417256_at -2.03 0.08 Mmp13 matrix metallopeptidase 13
doi:10.1371/journal.pone.0117607.t005
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Tnni2 in wild-type mice were enriched in the KEGG pathways viral myocarditis, immune/can-
cer, and proteolysis (adj.P, Benjamini< 0.1; S5 Table). However, no KEGG terms were signifi-
cantly enriched in Tnni2 correlates in MSTN-null mice.
Differential hubbing
Differential hubbing scores are listed in S6 Table. Fig. 4 illustrates extreme DH observed for
Ctnna1, Bmp8b, andMyl3 in wild-type vs. MSTN-null mice for highly correlated target genes
(|r| 0.9). For instance, there were over 2,000 genes highly co-expressed (correlated) with
Ctnna1 in MSTN-null mice, but only one gene was highly co-expressed with Ctnna1 in wild
type at 13.5 d.p.c. Interestingly, Ctnna1 was not differentially expressed (q = 0.56). Bmp8b was
also found to be differentially hubbed between wild-type and MSTN-null mice at 13.5 d.p.c.;
over 3,000 genes were highly co-expressed with Bmp8b in wild-type mice, while less than 1,000
genes were highly co-expressed with Bmp8b in MSTN-null mice. Fig. 5 contrasts the
Table 6. Top 10 RIF2 (wild type minus null) at d35.
ProbesetID RIF2 RIF1 Gene Symbol Gene Description
(1) Top Positive RIF2
1416551_at 7.84 4.1 Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
1416889_at 7.74 11.24 Tnni2 troponin I, skeletal, fast 2
1419606_a_at 7.00 2.41 Tnnt1 troponin T1, skeletal, slow
1416850_s_at 6.72 5.34 Cisd1 CDGSH iron sulfur domain 1
1417889_at 6.66 6.21 Apobec2 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2
(2) Top Negative RIF2
1423255_at -4.1 2.6 Atp6v1g1 ATPase, H+ transporting, lysosomal V1 subunit G1
1422156_a_at -3.76 5.27 Gm10420, Gm5978, Gm6139,
Gm8841, Gm8842, Rps2
predicted gene 1042, predicted gene 597, predicted gene 6139, predicted gene
8841, predicted gene 8842, ribosomal protein S2
1426731_at -3.43 4.78 Des desmin
1422613_a_at -3.32 4.8 Gm11362, Rpl7a predicted gene 11362, ribosomal protein L7A
1418996_a_at -3.17 1.96 Lyrm5 LYR motif containing 5
doi:10.1371/journal.pone.0117607.t006
Fig 3. Relationship between RIF1 and RIF2 at 13.5 d.p.c. and d35.
doi:10.1371/journal.pone.0117607.g003
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differences in expression patterns of genes highly correlated toMyl3 across genotypes at d35.
Expression data used in Fig. 5 are listed in S7 Table. The 5,500 genes highly correlated to and
co-expressed withMyl3 in wild-type mice were almost always downregulated, whereas the
1,189 co-expressed genes in MSTN-null mice were almost exclusively upregulated at d35. In
MSTN-null mice, theMyl3 differentially hubbed correlates were enriched for the KEGG path-
way term mmu04360: “Axon guidance”. In contrast, those genes highly correlated withMyl3
in wild-type mice were significantly enriched for the KEGG terms actin cytoskeleton, T/B cell
receptor signaling, viral myocarditis, Huntington's disease, cancer pathways, and ubiquitin-
mediated proteolysis (Benjamini p< 0.10; Table 7).
Discussion
Interpretation of genes differentially expressed during primary
myogenesis and postnatal skeletal muscle growth
Microarray analysis of tissues from MSTN-null and wild-type mice identified DE genes at both
13.5 d.p.c. and d35, whereas no DE genes (q< 0.05) were identified at 17.5 d.p.c. Ideally, com-
parisons would have been made using the same tissue sample from each of the timepoints.
However, obtaining single muscles from 13.5 d.p.c. and 17.5 d.p.c. embryos was not feasible
Fig 4. Differential wiring of co-correlated genes betweenWT and MSTN-null mice (|r| 0.9).
doi:10.1371/journal.pone.0117607.g004
Fig 5. Heat map of genes highly correlated toMyl3 in WT and MSTN-null mice at d35.
doi:10.1371/journal.pone.0117607.g005
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due to their small size at these stages of development. An important consequence is that no
comparisons can be made across timepoints in this study since the tissue types are not compa-
rable. It is also important to note that results from 13.5 and 17.5 d.p.c. may reflect gene expres-
sion changes in tissues other than muscle, even though myostatin is predominantly expressed
in muscle. We would also like to note that this study is a meta-analysis of a previous study and
that, although there is significant overlap, the number of DE genes identified at d35 in this
study differs from the results of the previous study in our lab [13]. This is because different
statistical methods were used in these two analyses. Despite the difference in the methodology
used to analyze differential expression in the current study, all of the DE genes validated
by real-time qPCR in our previous study were also significantly DE in this study (q<0.05;
S1 Table) [13].
Ontology-based enrichment analysis identified biological processes
related to myostatin-mediated changes in skeletal muscle growth and
metabolism.
DAVID ontology enrichment analyses identified significantly over-represented regulators rele-
vant to both muscle and adipose development. At 13.5 d.p.c., over-representation of the WNT
KEGG pathway was identified for genes DE by genotype. This result is consistent with a previ-
ous study from our lab that also identified a major role for WNT signal transduction in
MSTN-mediated skeletal muscle growth at the d35 postnatal timepoint [13]. The DE genes at
d35 were enriched for the DAVID terms muscle organ/tissue development, fatty acid
Table 7. KEGG pathway analysis of genes highly correlated with Myl3 at d35 in wild-type vs. MSTN-null mice.
Term Count % PValue List Total Pop Hits Pop Total Fold Enrichment Benjamini
mmu04810:Regulation of actin cytoskeleton 81 1.82 1.58E-06 1316 217 5738 1.63 2.98E-04
mmu04010:MAPK signaling pathway 93 2.09 5.21E-06 1316 265 5738 1.53 4.92E-04
mmu04662:B cell receptor signaling pathway 37 0.83 9.30E-06 1316 80 5738 2.02 5.86E-04
mmu03010:Ribosome 39 0.88 2.34E-05 1316 89 5738 1.91 1.11E-03
mmu04650:Natural killer cell mediated cytotoxicity 49 1.10 2.93E-05 1316 122 5738 1.75 1.11E-03
mmu04666:Fc gamma R-mediated phagocytosis 41 0.92 5.05E-05 1316 98 5738 1.82 1.59E-03
mmu05340:Primary immunodeﬁciency 20 0.45 8.99E-05 1316 36 5738 2.42 2.42E-03
mmu04670:Leukocyte transendothelial migration 46 1.03 1.56E-04 1316 119 5738 1.69 3.68E-03
mmu04062:Chemokine signaling pathway 64 1.44 1.78E-04 1316 182 5738 1.53 3.72E-03
mmu04660:T cell receptor signaling pathway 45 1.01 2.66E-04 1316 118 5738 1.66 5.02E-03
mmu04520:Adherens junction 32 0.72 3.52E-04 1316 76 5738 1.84 6.03E-03
mmu04144:Endocytosis 68 1.53 4.54E-04 1316 202 5738 1.47 7.13E-03
mmu05200:Pathways in cancer 100 2.25 5.95E-04 1316 323 5738 1.35 8.61E-03
mmu04142:Lysosome 44 0.99 6.75E-04 1316 119 5738 1.61 9.08E-03
mmu04120:Ubiquitin mediated proteolysis 48 1.08 1.19E-03 1316 136 5738 1.54 1.49E-02
mmu05416:Viral myocarditis 35 0.79 2.33E-03 1316 94 5738 1.62 2.72E-02
mmu04640:Hematopoietic cell lineage 32 0.72 2.49E-03 1316 84 5738 1.66 2.74E-02
mmu04612:Antigen processing and presentation 34 0.76 2.56E-03 1316 91 5738 1.63 2.65E-02
mmu04360:Axon guidance 45 1.01 3.15E-03 1316 131 5738 1.50 3.09E-02
mmu05016:Huntington's disease 58 1.30 5.71E-03 1316 183 5738 1.38 5.27E-02
mmu02010:ABC transporters 19 0.43 7.51E-03 1316 45 5738 1.84 6.56E-02
mmu04514:Cell adhesion molecules (CAMs) 49 1.10 1.05E-02 1316 154 5738 1.39 8.67E-02
doi:10.1371/journal.pone.0117607.t007
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metabolism, and mitochondria, which are all relevant to muscle and adipose growth. All
DAVID results are presented in S2 Table.
MicroRNA-regulated gene networks were over represented at 13.5 d.p.c.
Pathway Studio identified potential regulators within DE gene lists based on text mining of pre-
viously published results. Several microRNAs were identified as potential regulators from the
sub-network analysis at 13.5 d.p.c., includingMir29b1, Let7g,Mir139, andMir122. Since
microRNAs are involved in many early developmental processes, it is possible that they may be
involved in muscle and adipose development in pathways upstream or downstream of
MSTN signaling.
Fatty acid metabolism, myogenic, and muscle fiber type pathways were
over represented at d35
Pathway enrichment with Pathway Studio at d35 after birth identified a number of significantly
enriched pathways (p<0.05) relevant to muscle and adipose development. For example, several
myogenic factors’ sub-networks were significantly enriched, including networks regulated by
MEF2A, MEF2C, MYH1, and TNNT2 (S3 Table). MEF2C was previously found to be involved
in the formation of myofibers [25]. In addition, several sub-networks involved in fatty acid me-
tabolism were also significantly enriched at d35, including networks regulated by ADIPOQ,
CEBPA, FABP4, LDL, LEP, PGC1A, PPARG, SREBF1, and VLDL. PPARG, LEP, calmodulin,
and GH1 were linked to the largest numbers of differentially expressed genes at d35. UCP2, a
mitochondrial membrane transporter involved in energy balance regulation, was significantly
enriched as well (p = 0.00573; S3 Table). Notably, WNT4 pathway members were over repre-
sented at d35 (p = 0.0227), which is consistent with previously experimentally confirmed re-
sults from this study [13]. The transcription factor GATA5, which is an important regulator in
muscle development [26], was identified by Pathway Studio because its targets, including the
muscle fiber type development genesMyl2, Tnnc1,Myh7,Myl3, andMyh11, were significantly
over represented (p = 0.00133). These results indicate that genes DE due to MSTN loss of func-
tion at 13.5 d.p.c. and d35 include several important regulators of muscle and adipose develop-
ment. All Pathway Studio results are presented in S3 Table.
Known and novel transcriptional regulatory motifs were differentially
enriched in the presence or absence of functional myostatin at 13.5 d.p.
c. and d35
Previously, SMAD transcription factors have been implicated in MSTN signal trasnduction
[27]; however, not all promoters of MSTN-regulated genes contain SMAD binding sites. Using
DREME, several over-represented motifs were identified in DE genes at both 13.5 d.p.c. and
d35 (Figs. 1 and 2, Figures A and B in S1 File). Zinc-finger protein family (ZFP) binding site
was the most significant motif identified at 13.5 d.p.c. Binding sites for PLAGL1, a known bio-
marker of disease [28], were over represented in genes upregulated in WT at 13.5 d.p.c. Neither
Plagl1 (q = 0.72) nor Zfp187 (q = 0.54) was DE at 13.5 d.p.c. However, Plagl1 itself was signifi-
cantly 0.67-fold downregulated in WT at d35 (q = 0.01). In contrast, ZFP187 TF binding sites
were over represented in genes downregulated in WT at 13.5 d.p.c., while the gene itself was
significantly 1.21-fold upregulated in WT at d35 (q = 0.03). It is interesting that PLAGL1 bind-
ing sites were identified as over represented in genes that are more highly expressed in the WT
genotype, since the similar gene Plag1 was recently identified in a haplotype that had under-
gone a selective sweep in double-muscled Belgian Blue cattle [29].
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At d35, SMAD3 binding site was found to be the most over-represented motif in DE genes
upregulated in MSTN-null mice at d35, indicating its importance in MSTN signal transduction
during postnatal growth. SMAD3 has proved to be necessary and sufficient for MSTN signal
transduction during muscle development [30]. In addition, SP1 was identified as an over-rep-
resented motif in DE genes upregulated in WT at d35. Sp1 was a DE gene and 1.29-fold upre-
gulated in wild-type mice at d35. The SP1 transcription factor was reported to play an
important role in the transcriptional activity of genes [31] and induction of lipogenesis via
FOXO1 [32]. Further, SP1 is known to be important in skeletal muscle proliferation through
transcriptional regulation of fibroblast growth factor receptor 1 (FGFR1) [33,34], and differen-
tiation by regulation of ERK5/Sp1/Klf [35].
An important unanswered question addressed in this study is how MSTN signals to all of
the genes that it regulates. Besides SMAD3 and SP1, additional over-represented motifs were
identified in DE genes between MSTN-null and wild-type mice. These results are important be-
cause they suggest novel transcriptional regulators that MSTN may signal through to directly
or indirectly alter transcriptional regulation of genes within its signal transduction pathway.
However, these sequence motifs have no known transcription factors that bind to them. It is
possible that currently unknown sequence motifs could regulate MSTN-reactive genes at these
sites. These results provide novel insights into possible mechanisms of transcriptional regula-
tion in the context of MSTN signal transduction and indicate that there is still much to learn
about MSTN signaling.
Co-expression methods identified genes known to interact with
myostatin as well as novel putative pathway components
Application of the RIF and PIF algorithms [11] to all genes in this dataset (over 34,000 annotat-
ed genes) allowed genes to be ranked as regulators, not just transcription factors. This allowed
novel regulatory genes to be identified in this study. All PIF scores are provided in S8 Table.
Genes with the 20 highest PIF scores at 13.5 d.p.c. (Table 8) were shown by DAVID analysis to
be enriched for several RNA and protein modification terms, including protein acetylation,
methylation, and RNA-binding (Benjamini p<0.05; S9 Table). Several cell cycle and cancer-re-
lated genes were also over represented. The highest PIF value genes from d35 (Table 9) appear
to be related to fiber type changes between MSTN-null and wild-type mice (e.g., Tpm1, Ckm,
Mylpf, Actn3,Myh4, Tnnt3, Actc1,Myh1, and Tnni2). A DAVID enrichment analysis of the
top 20 PIF genes confirms that these genes are involved in a multitude of muscle-specific struc-
tural and metabolic functions consistent with fiber type changes that occur due to MSTN inac-
tivation (S9 Table).
Several known regulators of skeletal muscle growth were identified using the RIF method.
Potentially novel regulators that fit closely with known MSTN functions were also identified.
The following passages present several novel possibilities regarding regulation of MSTN
signal transduction.
At 13.5 d.p.c., voltage-dependent anion channel 1 (Vdac1) and thymosin B4 (Tmsb4x) were
identified among the top ten RIF2 scores. The Vdac1 gene encodes a mitochondrial porin that
appears to regulate mitochondrial function by regulating the metabolites and ions that can
enter the mitochondria [36,37]. A recent study reports that treatment of HeLa cells with
MSTN leads to increases in VDAC1-mediated apoptosis via BAX [38]. Interestingly, Vdac1
knockout mice also have impaired exercise capacity and reduced glucose tolerance [36]. The
Tmsb4x gene has been proposed to be involved in wound healing and muscle regeneration.
Studies in C2C12 and satellite cell–derived primary myocytes and myoblasts indicate that
Tmsb4x is more highly expressed at muscle wound sites and that it acts as a myoblast
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chemoattractant during muscle regeneration [39]. In the mdx mouse model of muscular dys-
trophy, chronic administration of TMSB4X was also found to increase the number of regener-
ating skeletal muscle fibers [40].
The Sox2 gene was identified as a top-ten ranked RIF1 gene at 13.5 d.p.c. Several studies
have documented the role of SOX2 in SMAD-mediated TGFβ signal transduction during em-
bryonic development [41]. In addition, Sox2 sustained expression is promoted by TGFβ signal
transduction to promote embryonic stem cell self renewal [42]. Therefore, it is plausible that al-
tered MSTN signal transduction, which acts through TGFβ, may impact SOX2 signal transduc-
tion and processes associated with stem cell renewal. Since whole embryos were used for 13.5
d.p.c., it is not possible to determine which tissues are actually affected.
At d35, Apobec2 andMmp13 were identified as potential regulators based on high RIF2 and
RIF1 scores, respectively. The APOBEC2 protein is an RNA-editing enzyme that is expressed
almost exclusively in striated muscle and appears to be important in fiber type determination.
Mouse knockouts of Apobec2 tend to have a greater ratio of slow to fast twitch muscle, 15-20%
reduction in body mass, and evidence of mild myopathy in aged mice [43]. Vonica et al. have
defined the specific roles of APOBEC2 in right/left axis patterning in development, terminal
Table 8. Top 20 PIF at 13.5 d.p.c. *
ProbesetID PIF
Score
13.5 dpc
q-value
Gene Symbol Gene Description
1438009_at 90.96 0.0877 Hist1h2ab, Hist1h2ac, Hist1h2ad, Hist1h2ae,
Hist1h2ag, Hist1h2ah, Hist1h2ai, Hist1h2an,
Hist1h2ao, Hist1h2ap
histone cluster 1, H2ab, histone cluster 1, H2ac, histone cluster 1,
H2ad, histone cluster 1, H2ae, histone cluster 1, H2ag, histone
cluster 1, H2ah, histone cluster 1, H2ai, histone cluster 1, H2an,
histone cluster 1, H2ao, histone cluster 1, H2ap
1455725_a_at 81.92 0.0527 Gm12657, Gm6749, Gm8029, H3f3a, H3f3b,
H3f3c
predicted gene 12657, predicted pseudogene 6749, predicted
gene 8029, H3 histone, family 3A, H3 histone, family 3B, H3
histone, family 3C
1420880_a_at 81.02 0.0911 Ywhab tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, beta polypeptide
1450849_at 76.60 0.0206 Hnrnpu heterogeneous nuclear ribonucleoprotein U
1416365_at 75.60 0.0524 Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1
1451285_at 74.64 0.0783 Fus fusion, derived from t(12;16) malignant liposarcoma (human)
1422848_a_at 72.85 0.0783 Pabpn1 poly(A) binding protein, nuclear 1
1437497_a_at 72.82 0.0295 Hsp90aa1 heat shock protein 90, alpha (cytosolic), class A member 1
1450740_a_at 70.22 0.0308 Mapre1 microtubule-associated protein, RP/EB family, member 1
1423667_at 69.78 0.0788 Mat2a methionine adenosyltransferase II, alpha
1460339_at 69.52 0.0961 Psma4 proteasome (prosome, macropain) subunit, alpha type 4
1426407_at 68.61 0.0911 Celf1 CUGBP, Elav-like family member 1
1438390_s_at 67.97 0.0444 Pttg1 pituitary tumor-transforming gene 1
1438403_s_at 66.91 0.0487 Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-
coding RNA)
1420613_at 66.86 0.0519 Ptp4a2 protein tyrosine phosphatase 4a2
1448425_at 66.77 0.0420 Eif3a eukaryotic translation initiation factor 3, subunit A
1436884_x_at 66.66 0.0980 Ewsr1 Ewing sarcoma breakpoint region 1
1455283_x_at 65.51 0.0719 Ndufs8 NADH dehydrogenase (ubiquinone) Fe-S protein 8
1453229_s_at 65.50 0.0914 Uqcrh ubiquinol-cytochrome c reductase hinge protein
1455546_s_at 65.10 0.0652 Sf3a2 splicing factor 3a, subunit 2
* The top 20 PIF scores with a q-value < 0.10 are presented. For multiple probesetIDs with the same annotation, the probesetID with smallest q-value
was saved.
doi:10.1371/journal.pone.0117607.t008
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differentiation of muscle, and inhibition of TGFβ signal transduction [44]. Based on studies in
zebrafish, it has been suggested that APOBEC2 may mediate its effects in part by altering meth-
ylation patterns [44,45]. The role of MMP13 in skeletal muscle has been suggested to center
around myoblast migration and differentiation during muscle regeneration. Pharmacological
blockade of MMP13 in C2C12 cells leads to reduced myoblast migration and differentiation,
whereas overexpression leads to improved myoblast migration. Expression ofMmp13 appears
to be increased during muscle repair as well as following myoblast fusion during myotube for-
mation. Although its exact role is unknown, it has been suggested to alter extracellular matrix
remodeling during muscle regeneration [46].
The identification of Atp2a2 (a.k.a. Serca2a) as the top-ranked RIF2 gene at d35 is particu-
larly noteworthy, because it was previously identified as a potential modifier of MSTN in a
large F2 mouse study [47]. The ATP2A2 calcium pump affects sarcoplasmic reticulum function
and muscle fiber type. Transgenic Atp2a2mice exhibit cardiac hypertrophy [47–50]. Further-
more, pharmacological inhibition of SMAD2 in cardiomyocytes indicates that TGFβ/SMAD2
signaling regulates ATP2A2 function [51]. Therefore, it is very plausible that MSTN may regu-
late ATP2A2 in skeletal muscle to mediate changes in muscle fiber type and size.
Differentially hubbed genes that may act as regulators or key mediators in muscle and adi-
pose development in the context of MSTN are listed in S1 Table. Ctnna1 was identified as dif-
ferentially hubbed at 13.5 d.p.c. despite not being DE, which indicates that MSTN may affect
some regulators both directly and indirectly so as to cause or influence the differential
Table 9. Top 20 PIF at d35*.
ProbesetID PIF
Score
d35 q-
value
Gene Symbol Gene Description
1423049_a_at 105.15 0.0584 Tpm1 tropomyosin 1, alpha
1417614_at 104.42 0.0645 Ckm creatine kinase, muscle
1417653_at 101.76 0.0538 Pvalb parvalbumin
1448371_at 101.03 0.0230 Mylpf myosin light chain, phosphorylatable, fast skeletal muscle
1418677_at 100.56 0.0022 Actn3 actinin alpha 3
1427026_at 98.24 0.0298 Myh4 myosin, heavy polypeptide 4, skeletal muscle
1417951_at 96.84 0.0594 Eno3 enolase 3, beta muscle
1455736_at 96.20 0.0047 Mybpc2 myosin binding protein C, fast-type
1456588_x_at 96.03 0.0271 Cox5b
LOC100046079
cytochrome c oxidase, subunit Vb, cytochrome c oxidase, subunit 5B, mitochondrial-
like
1450118_a_at 94.88 0.0517 Tnnt3 troponin T3, skeletal, fast
1418373_at 94.26 0.0283 Pgam2 phosphoglycerate mutase 2
1415927_at 93.14 0.0122 Actc1 actin, alpha, cardiac muscle 1
1416624_a_at 92.19 0.0524 2810422J05Rik
Uba52
RIKEN cDNA 2810422J05 gene, ubiquitin A-52 residue ribosomal protein fusion
product 1
1417373_a_at 91.83 0.0255 Tuba4a tubulin, alpha 4A
1419737_a_at 91.42 0.0102 Ldha lactate dehydrogenase A
1418062_at 91.42 0.0121 Eef1a2 eukaryotic translation elongation factor 1 alpha 2
1460561_x_at 90.62 0.0041 Sepw1 selenoprotein W, muscle 1
1427868_x_at 90.48 0.0089 Myh1 myosin, heavy polypeptide 1, skeletal muscle, adult
1426143_at 90.05 0.0358 Trdn triadin
1438609_x_at 90.02 0.0819 Tnni2 troponin I, skeletal, fast 2
*The top 20 PIF scores with a q-value < 0.10 are presented. For multiple probesetIDs with the same annotation, the probesetID with smallest q-value
was saved.
doi:10.1371/journal.pone.0117607.t009
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expression of target genes. Similarly, Bmp8b was identified to have over 2,000 genes differen-
tially hubbed in wild-type versus MSTN-null mice (Fig. 4). A recent report demonstrated that
BMP8B directly regulates thermogenesis in brown adipose tissues [52], which indicates that
MSTN may alter adipose metabolism through BMP8B. In addition, recent research identified a
mutation inMyl3 that can cause hypertrophic cardiomyopathy in infants [53]. In our study,
over 4,000 genes were differentially hubbed withMyl3 in wild-type compared to MSTN-null
mice. Interestingly, significant enrichment of biological pathways involved in muscle develop-
ment and disease occurred only in wild-type mice (Table 7, adj.P, Benjamini< 0.1), which is
consistent with previous findings that MSTN plays an important role in phenotypes such as
muscle hypertrophy or disease caused by muscle dysfunction [54,55].
Conclusions
Differentially expressed genes were identified between wild-type and MSTN-null mice during
primary myogenesis and postnatal muscle growth, but not during secondary myogenesis. In
addition, co-expression analyses identified several known and novel regulators or pathway ef-
fectors of myostatin. Regulators with known roles in muscle growth, TGFβ signaling, and mito-
chondrial function were identified by the RIF method. Another important finding was that
genes not DE or a priori considered regulators were identified as important in differentiating
wild-type and MSTN-null mice. These potential regulators would not have been identified if
analyses had been limited to considering only transcription factors as regulators. Furthermore,
motif enrichment analyses identified several transcription factor binding sites in genes differ-
entially expressed due to Mstn genotype. This study demonstrates that all genes must be con-
sidered as potential regulators when trying to identify critical control points of pathway
circuitry.
Supporting Information
S1 File. Supporting figures. Figure A in S1 File.Over-represented motifs in genes upregu-
lated in WT at d35. Figure B in S1 File. Over-represented motifs in genes upregulated in
MSTN-null at d35.
(PDF)
S1 Table. Results of microarray analysis.
(XLSX)
S2 Table. Results of DAVID analysis from DE genes at 13.5 d.p.c. and d35.
(XLSX)
S3 Table. Results of pathway analysis from DE genes at 13.5 d.p.c. and d35.
(XLSX)
S4 Table. Results of the RIF analysis (Zscore).
(XLSX)
S5 Table. Over-represented KEGG terms for genes highly correlated with Tnni2 at d35.
(XLSX)
S6 Table. Results of differential hubbing.
(XLSX)
S7 Table. Data for Fig. 5.
(XLSX)
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
PLOS ONE | DOI:10.1371/journal.pone.0117607 February 19, 2015 16 / 19
S8 Table. Results of the PIF analysis.
(XLSX)
S9 Table. DAVID enrichment of extreme PIF values.
(XLSX)
Author Contributions
Conceived and designed the experiments: JMR. Performed the experiments: CAP. Analyzed
the data: JEK XRY. Wrote the paper: XRY JEK CAP DWC JMR.
References
1. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, et al. (2006) A mutation creating a potential illegitimate
microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38: 813–818.
PMID: 16751773
2. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-
beta superfamily member. Nature 387: 83–90. PMID: 9139826
3. McPherron AC, Lee SJ (1997) Double muscling in cattle due to mutations in the myostatin gene. Proc
Natl Acad Sci U S A 94: 12457–12461. PMID: 9356471
4. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, et al. (2002) Functional improvement
of dystrophic muscle by myostatin blockade. Nature 420: 418–421. PMID: 12459784
5. Feldman BJ, Streeper RS, Farese RV Jr, Yamamoto KR (2006) Myostatin modulates adipogenesis to
generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103: 15675–15680.
PMID: 17030820
6. Duxson MJ, Usson Y, Harris AJ (1989) The origin of secondary myotubes in mammalian skeletal mus-
cles: ultrastructural studies. Development 107: 743–750. PMID: 2483685
7. Matsakas A, Otto A, Elashry MI, Brown SC, Patel K (2010) Altered primary and secondary myogenesis
in the myostatin-null mouse. Rejuvenation Res 13: 717–727. doi: 10.1089/rej.2010.1065 PMID:
21204650
8. Ontell M, Kozeka K (1984) Organogenesis of the mouse extensor digitorum logus muscle: a quantita-
tive study. Am J Anat 171: 149–161. PMID: 6496373
9. Hudson NJ, Reverter A, Dalrymple BP (2009) A differential wiring analysis of expression data correctly
identifies the gene containing the causal mutation. PLoS Comput Biol 5: e1000382. doi: 10.1371/
journal.pcbi.1000382 PMID: 19412532
10. Reverter A, Chan EK (2008) Combining partial correlation and an information theory approach to the re-
versed engineering of gene co-expression networks. Bioinformatics 24: 2491–2497. doi: 10.1093/
bioinformatics/btn482 PMID: 18784117
11. Reverter A, Hudson NJ, Nagaraj SH, Perez-Enciso M, Dalrymple BP (2010) Regulatory impact factors:
unraveling the transcriptional regulation of complex traits from expression data. Bioinformatics 26:
896–904. doi: 10.1093/bioinformatics/btq051 PMID: 20144946
12. Koesterke L, Milfeld K, Vaughn MW, Stanzione D, Koltes JE, et al. (2013) Optimizing the PCIT algo-
rithm on stampede's Xeon and Xeon Phi processors for faster discovery of biological networks. In: Pro-
ceedings of the Conference on Extreme Science and Engineering Discovery Environment: Gateway to
Discovery.
13. Steelman CA, Recknor JC, Nettleton D, Reecy JM (2006) Transcriptional profiling of myostatin-knock-
out mice implicatesWnt signaling in postnatal skeletal muscle growth and hypertrophy. FASEB J 20:
580–582. PMID: 16423875
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normaliza-
tion, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264.
PMID: 12925520
15. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) affy–analysis of Affymetrix GeneChip data at the
probe level. Bioinformatics 20: 307‱315. PMID: 14960456
16. Smyth GK (2005) Limma: linear models for microarray data. In: 'Bioinformatics and Computational Biol-
ogy Solutions using R and Bioconductor' Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds),
Springer, New York: 397–420.
17. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S
A 100: 9440–9445. PMID: 12883005
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
PLOS ONE | DOI:10.1371/journal.pone.0117607 February 19, 2015 17 / 19
18. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists
using DAVID bioinformatics resources. Nature Protocols 4: 44–57. doi: 10.1038/nprot.2008.211 PMID:
19131956
19. Nikitin A, Egorov S, Daraselia N, Mazo I (2003) Pathway studio–the analysis and navigation of molecu-
lar networks. Bioinformatics 19: 2155–2157. PMID: 14594725
20. Bailey TL (2011) DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27:
1653–1659. doi: 10.1093/bioinformatics/btr261 PMID: 21543442
21. Gupta S, Stamatoyannopoulos JA, Bailey TL, Noble WS (2007) Quantifying similarity between motifs.
Genome Biol 8: R24. PMID: 17324271
22. Sandelin A, AlkemaW, Engstrom P, WassermanWW, Lenhard B (2004) JASPAR: an open-access da-
tabase for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91–94. PMID:
14681366
23. Newburger DE, Bulyk ML (2009) UniPROBE: an online database of protein binding microarray data on
protein-DNA interactions. Nucleic Acids Res 37: D77–82. doi: 10.1093/nar/gkn660 PMID: 18842628
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unifica-
tion of biology. The Gene Ontology Consortium. Nat Genet 25: 25–29. PMID: 10802651
25. Alexander MS, Shi X, Voelker KA, Grange RW, Garcia JA, et al. (2010) Foxj3 transcriptionally activates
Mef2c and regulates adult skeletal muscle fiber type identity. Dev Biol 337: 396–404. doi: 10.1016/j.
ydbio.2009.11.015 PMID: 19914232
26. Turbendian HK, Gordillo M, Tsai SY, Lu J, Kang G, et al. (2013) GATA factors efficiently direct cardiac
fate from embryonic stem cells. Development 140: 1639–1644. doi: 10.1242/dev.093260 PMID:
23487308
27. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci
U S A 98: 9306–9311. PMID: 11459935
28. Peille AL, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, et al. (2013) Prognostic value of PLAGL1-
specific CpG site methylation in soft-tissue sarcomas. PLoS One 8: e80741. doi: 10.1371/journal.
pone.0080741 PMID: 24260468
29. Druet T, Ahariz N, Cambisano N, Tamma N, Michaux C, et al. (2014) Selection in action: dissecting the
molecular underpinnings of the increasing muscle mass of Belgian Blue Cattle. BMCGenomics 15:
796. doi: 10.1186/1471-2164-15-796 PMID: 25228463
30. Goodman CA, McNally RM, Hoffmann FM, Hornberger TA (2013) Smad3 Induces Atrogin-1, Inhibits
mTOR and Protein Synthesis, and Promotes Muscle Atrophy In Vivo. Mol Endocrinol.
31. Li L, Davie JR (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192: 275–
283. doi: 10.1016/j.aanat.2010.07.010 PMID: 20810260
32. Deng X, ZhangW, I OS, Williams JB, Dong Q, et al. (2012) FoxO1 inhibits sterol regulatory element-
binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c. J Biol
Chem 287: 20132–20143. doi: 10.1074/jbc.M112.347211 PMID: 22511764
33. Parakati R, DiMario JX (2002) Sp1- and Sp3-mediated transcriptional regulation of the fibroblast growth
factor receptor 1 gene in chicken skeletal muscle cells. J Biol Chem 277: 9278–9285. PMID: 11756440
34. Parakati R, DiMario JX (2013) Repression of myoblast proliferation and fibroblast growth factor receptor
1 promoter activity by KLF10 protein. J Biol Chem 288: 13876–13884. doi: 10.1074/jbc.M113.457648
PMID: 23569208
35. Sunadome K, Yamamoto T, Ebisuya M, Kondoh K, Sehara-Fujisawa A, et al. (2011) ERK5 regulates
muscle cell fusion through Klf transcription factors. Dev Cell 20: 192–205. doi: 10.1016/j.devcel.2010.
12.005 PMID: 21316587
36. Anflous-Pharayra K, Cai ZJ, CraigenWJ (2007) VDAC1 serves as a mitochondrial binding site for hexo-
kinase in oxidative muscles. Biochim Biophys Acta 1767: 136–142. PMID: 17207767
37. Shoshan-Barmatz V, Mizrachi D (2012) VDAC1: from structure to cancer therapy. Front Oncol 2: 164.
doi: 10.3389/fonc.2012.00164 PMID: 23233904
38. Liu Y, Cheng H, Zhou Y, Zhu Y, Bian R, et al. (2013) Myostatin induces mitochondrial metabolic alter-
ation and typical apoptosis in cancer cells. Cell Death Dis 4: e494. doi: 10.1038/cddis.2013.31 PMID:
23412387
39. Tokura Y, Nakayama Y, Fukada S, Nara N, Yamamoto H, et al. (2011) Muscle injury-induced thymosin
beta4 acts as a chemoattractant for myoblasts. J Biochem 149: 43–48. doi: 10.1093/jb/mvq115 PMID:
20880960
40. Spurney CF, Cha HJ, Sali A, Pandey GS, Pistilli E, et al. (2010) Evaluation of skeletal and cardiac mus-
cle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. PLoS
One 5: e8976. doi: 10.1371/journal.pone.0008976 PMID: 20126456
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
PLOS ONE | DOI:10.1371/journal.pone.0117607 February 19, 2015 18 / 19
41. Gaarenstroom T, Hill CS (2014) TGF-beta signaling to chromatin: How Smads regulate transcription
during self-renewal and differentiation. Semin Cell Dev Biol.
42. Xu RH, Sampsell-Barron TL, Gu F, Root S, Peck RM, et al. (2008) NANOG is a direct target of
TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3: 196–206. doi: 10.1016/j.
stem.2008.07.001 PMID: 18682241
43. Sato Y, Probst HC, Tatsumi R, Ikeuchi Y, Neuberger MS, et al. (2010) Deficiency in APOBEC2 leads to
a shift in muscle fiber type, diminished body mass, and myopathy. J Biol Chem 285: 7111–7118. doi:
10.1074/jbc.M109.052977 PMID: 20022958
44. Vonica A, Rosa A, Arduini BL, Brivanlou AH (2011) APOBEC2, a selective inhibitor of TGFbeta signal-
ing, regulates left-right axis specification during early embryogenesis. Dev Biol 350: 13–23. doi: 10.
1016/j.ydbio.2010.09.016 PMID: 20880495
45. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, et al. (2008) DNA demethylation in zebrafish in-
volves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135: 1201–1212. doi: 10.1016/j.
cell.2008.11.042 PMID: 19109892
46. Lei H, Leong D, Smith LR, Barton ER (2013) Matrix metalloproteinase 13 is a new contributor to skeletal
muscle regeneration and critical for myoblast migration. Am J Physiol Cell Physiol 305: C529–538. doi:
10.1152/ajpcell.00051.2013 PMID: 23761625
47. Cheng Y, Rachagani S, Canovas A, Mayes MS, Tait RG Jr, et al. (2013) Body composition and gene
expression QTL mapping in mice reveals imprinting and interaction effects. BMCGenet 14: 103. doi:
10.1186/1471-2156-14-103 PMID: 24165562
48. Lipskaia L, Lompre AM (2004) Alteration in temporal kinetics of Ca2+ signaling and control of growth
and proliferation. Biol Cell 96: 55–68. PMID: 15093128
49. Swift F, Franzini-Armstrong C, Oyehaug L, Enger UH, Andersson KB, et al. (2012) Extreme sarcoplas-
mic reticulum volume loss and compensatory T-tubule remodeling after Serca2 knockout. Proc Natl
Acad Sci U S A 109: 3997–4001. doi: 10.1073/pnas.1120172109 PMID: 22355118
50. Vangheluwe P, Tjwa M, Van Den Bergh A, LouchWE, Beullens M, et al. (2006) A SERCA2 pump with
an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life
span. J Mol Cell Cardiol 41: 308–317. PMID: 16814319
51. Bjornstad JL, Skrbic B, Marstein HS, Hasic A, Sjaastad I, et al. (2012) Inhibition of SMAD2 phosphory-
lation preserves cardiac function during pressure overload. Cardiovasc Res 93: 100–110. doi: 10.
1093/cvr/cvr294 PMID: 22049534
52. Whittle AJ, Carobbio S, Martins L, Slawik M, Hondares E, et al. (2012) BMP8B increases brown adi-
pose tissue thermogenesis through both central and peripheral actions. Cell 149: 871–885. doi: 10.
1016/j.cell.2012.02.066 PMID: 22579288
53. Jay A, Chikarmane R, Poulik J, Misra VK (2013) Infantile hypertrophic cardiomyopathy associated with
a novel MYL3 mutation. Cardiology 124: 248–251. doi: 10.1159/000347138 PMID: 23594557
54. Chien YH, Han DS, HwuWL, Thurberg BL, YangWS (2013) Myostatin and insulin-like growth factor I:
potential therapeutic biomarkers for pompe disease. PLoS One 8: e71900. doi: 10.1371/journal.pone.
0071900 PMID: 23967261
55. Cotten SW, Kornegay JN, Bogan DJ, Wadosky KM, Patterson C, et al. (2013) Genetic myostatin de-
crease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin pro-
teasome system despite enhancing the severity of disease. Am J Transl Res 6: 43–53. PMID:
24349620
Co-Expression Network Analysis of Myostatin Regulation at 3 Timepoints
PLOS ONE | DOI:10.1371/journal.pone.0117607 February 19, 2015 19 / 19
